Releases
KMDA
5.63
+0.54%
0.03
  • All
  • Financials
  • Insiders
More
Webull provides the latest Kamada Ltd (KMDA) stock and general news. This information may help you make smarter investment decisions.
About KMDA
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.